Developer docs
API playgroundTry for free, no card

Search company profiles

Leucine Rich Bio

Full company profile

uuid0004spt

Namestring
Leucine Rich Bio
Legal namestring
Leucine Rich Bio Pvt Ltd
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Leucine Rich Bio is a Bengaluru-based biotechnology company founded in 2014 that operates as India's first and only microbiome-focused genomics business. Its core offering, the BugSpeaks test, sequences a consumer's gut microbiome and generates a personalized three-month diet plan, supported by a proprietary database of 2,000 Indian and 10,000 global microbiome profiles derived from 20,000+ samples analyzed to date. The technology stack includes a proprietary RYCH Index for intestinal microbial health and a gut-microbial-based disease susceptibility assessment method, both covered by filed (pending) patents. A registered clinical trial published in 2024 reported a 20% reduction in HbA1c levels in Type 2 diabetes patients following BugSpeaks recommendations over three months, providing clinically validated outcomes.

The company generates revenue through three primary streams: a one-time direct-to-consumer fee of Rs 10,000 per BugSpeaks kit sold via bugspeaks.com and leucinerichbio.com; a RychBiome supplements line that monetizes the underlying science through consumable products; and contract research services for pharmaceutical companies, CROs, and academic groups. Distribution is direct-to-consumer in India and partner-led internationally, with channel relationships in Malaysia (Trinature Wellness), UAE (Medsol Diagnostics), Philippines, and Brazil. The company is accredited under NABL (the first in India's microbiome testing space), NABH for microbiome research, and ISO/IEC 17025:2017, and is positioning itself as a category-defining platform through sub-brands BugSpeaks, RychBiome, and the World of Microbiome conference, with an Faecal Microbiota Transplant service and skin/oral/vaginal microbiome tests in development.

Short descriptiontext

Leucine Rich Bio is an India-based microbiome genomics company that sells the BugSpeaks gut microbiome test directly to consumers, develops RychBiome supplements, and offers microbiome research services to pharmaceutical and academic clients across India, Malaysia, UAE, the Philippines, and Brazil.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbiome testing, gut microbiome analysis, personalized nutrition, microbiome diagnostics, probiotic supplements
Industry4 codes
PRIMARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHSADAFAH
Gut Health & Digestive Nutrition (IBS, GERD, Elimination Diets)
SECONDARYHLAAAFAK
Microbiome Clinical Development & Translational Services (trial design, endpoints, sampling)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Food (Health) Supplement Retailers456191
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
Microbiome Diagnostics
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1BugSpeaks Diagnostic Test
TypeOne Time License
Description

Direct-to-consumer microbiome analysis testing service. Customers purchase the BugSpeaks test kit which includes gut microbiome analysis and generates a personalized three-month diet plan based on individual microbial profiles.

yourstory.com
2RychBiome Supplements
TypeOthers
Description

Deep science nutritional supplements developed based on microbiome research, sold as a complementary product line to the diagnostic testing service.

leucinerichbio.com
3Collaborative Research Services
TypeProfessional Services
Description

Research services for CROs, pharmaceutical companies, and academic researchers including cohort studies, deep science ingredient discovery, and drug discovery targeting the microbiome.

yourstory.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1BugSpeaks Microbiome Test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

BugSpeaks test priced at Rs 10,000 (Indian Rupees), which includes gut microbiome analysis and a personalized three-month diet plan based on individual microbial profiles.

yourstory.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 3 records shown
1BugSpeaks
Description

Microbiome profiling platform offering gut microbiome analysis with personalized nutritional recommendations

leucinerichbio.com
+2 more records
Core offering1 text field

Leucine Rich Bio provides gut microbiome analysis through its BugSpeaks test, which measures bacterial diversity and generates personalized three-month diet plans based on individual microbial profiles. The company also offers RychBiome deep-science nutritional supplements, microbiome-based skincare products, and collaborative research services for pharmaceutical companies and CROs covering cohort studies, ingredient discovery, and microbiome-targeted drug discovery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 20% reduction in HbA1c levels in Type 2 diabetes patients following BugSpeaks nutritional recommendations for 3 months
+2 more records
Product overview1 text field

Leucine Rich Bio operates as a unified platform centered on microbiome science, consisting of BugSpeaks (core microbiome profiling diagnostic), RychBiome (deep science supplements), World of Microbiome (research conference), and upcoming Faecal Microbiota Transplant services. BugSpeaks serves as the primary diagnostic offering generating personalized nutritional recommendations, while RychBiome extends into therapeutic supplements. Research services for CROs and pharma companies cover gut, oral, skin, vaginal, soil, and built environment microbiomes through collaborative research, cohort studies, deep science ingredients, and drug discovery.

Product and service4 records
1BugSpeaks
CategoryMicrobiome Diagnostic Test
Description

Microbiome profiling test that measures bacterial diversity and generates personalized three-month diet plans based on individual microbial profiles for personalized nutrition and preventive healthcare. Sold directly to consumers.

2RychBiome Supplements
3Microbiome-based Skincare Product
CategoryMicrobiome-based Skincare
Description

India's first microbiome-based skincare product, leveraging the company's microbiome science expertise to enter the dermatology and skincare market.

4Collaborative Research Services
CategoryResearch Services
Description

Research services for CROs, pharmaceutical companies, and academic researchers including cohort studies, deep science ingredient discovery, and drug discovery targeting the microbiome. Covers gut, oral, skin, vaginal, soil, and built environment microbiomes.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with Trinature Wellness to launch BugSpeaks microbiome analysis test in Malaysia, expanding the company's presence in Southeast Asia through a local distribution partner.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with Medsol Diagnostics in UAE to advance microbiome health solutions in the Middle East region, leveraging local healthcare infrastructure and market access.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International expansion through partnerships in Philippines, Brazil, and UAE for distribution of BugSpeaks microbiome analysis services in these markets.

4YUN NV
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Mentioned alongside YUN NV as both being key players in the microbiome space, with Leucine Rich Bio's launch of India's first microbiome-based skincare product highlighted as a significant development.

yourstory.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Viome is a US-based direct-to-consumer microbiome testing company offering gut microbiome analysis with personalized nutrition recommendations. It is the closest global direct competitor to BugSpeaks, operating in the same product category with similar technology (metatranscriptomic sequencing) and targeting health-conscious consumers.

TypeDirect peer
Description

DayTwo provides microbiome-based personalized nutrition with clinical validation specifically for Type 2 diabetes and metabolic conditions, mirroring Leucine Rich Bio's clinical trial focus on HbA1c reduction. Both companies target the intersection of microbiome analytics and glycemic management.

TypeDirect peer
Description

ZOE is a UK/US consumer health company combining microbiome testing with blood sugar and blood fat analysis to deliver personalized nutrition. Like Leucine Rich Bio, ZOE sells DTC microbiome tests with accompanying diet recommendations, often at premium price points for health-conscious consumers.

TypeDirect peer
Description

Atlas Biomed is a UK-based microbiome and DNA testing company offering gut microbiome analysis with personalized dietary recommendations. It competes directly in the DTC consumer microbiome testing space and is often compared to Viome and other BugSpeaks-like offerings.

TypeDirect peer
Description

Sun Genomics offers personalized microbiome testing and custom probiotic formulations direct-to-consumer in the US. The combination of microbiome testing plus a supplement line (Floré) is directly analogous to Leucine Rich Bio's BugSpeaks plus RychBiome model.

TypeDirect peer
Description

Biohm Health provides gut and vaginal microbiome testing with personalized probiotic and prebiotic recommendations. It overlaps with both Leucine Rich Bio's core gut offering and its planned expansion into vaginal microbiome testing.

TypeDirect peer
Description

Thryve Inside (formerly Thryve) provides gut microbiome testing and analysis services, including white-label microbiome testing for brands. It is comparable to Leucine Rich Bio both in its DTC testing business and its B2B research and co-development services for partner brands and researchers.

8Daye
TypeEmerging player
Description

Daye is a UK-based femtech company offering vaginal microbiome testing alongside period care products. It is an emerging competitor specifically in the vaginal microbiome category that Leucine Rich Bio plans to enter in 2026.

9MapMyGut (by Carbiotix)
TypeEmerging player
Description

Carbiotix is a Swedish microbiome testing and prebiotic fiber ingredient company offering gut microbiome analysis. It overlaps with Leucine Rich Bio on the diagnostics side and on the gut-health supplement/ingredient adjacency through RychBiome.

TypeEmerging player
Description

Siolta Therapeutics is a clinical-stage microbiome therapeutics company developing live biotherapeutic products for inflammatory diseases. While focused on therapeutics rather than diagnostics, Siolta is comparable in its deep microbiome R&D approach and represents the kind of therapeutic-direction opportunity Leucine Rich Bio could pursue with its Faecal Microbiota Transplant service.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Leucine Rich Bio

Microbiome Diagnosticsleucinerichbio.com

Leucine Rich Bio is an India-based microbiome genomics company that sells the BugSpeaks gut microbiome test directly to consumers, develops RychBiome supplements, and offers microbiome research services to pharmaceutical and academic clients across India, Malaysia, UAE, the Philippines, and Brazil.

What Leucine Rich Bio does

Leucine Rich Bio is a Bengaluru-based biotechnology company founded in 2014 that operates as India's first and only microbiome-focused genomics business. Its core offering, the BugSpeaks test, sequences a consumer's gut microbiome and generates a personalized three-month diet plan, supported by a proprietary database of 2,000 Indian and 10,000 global microbiome profiles derived from 20,000+ samples analyzed to date. The technology stack includes a proprietary RYCH Index for intestinal microbial health and a gut-microbial-based disease susceptibility assessment method, both covered by filed (pending) patents. A registered clinical trial published in 2024 reported a 20% reduction in HbA1c levels in Type 2 diabetes patients following BugSpeaks recommendations over three months, providing clinically validated outcomes.

The company generates revenue through three primary streams: a one-time direct-to-consumer fee of Rs 10,000 per BugSpeaks kit sold via bugspeaks.com and leucinerichbio.com; a RychBiome supplements line that monetizes the underlying science through consumable products; and contract research services for pharmaceutical companies, CROs, and academic groups. Distribution is direct-to-consumer in India and partner-led internationally, with channel relationships in Malaysia (Trinature Wellness), UAE (Medsol Diagnostics), Philippines, and Brazil. The company is accredited under NABL (the first in India's microbiome testing space), NABH for microbiome research, and ISO/IEC 17025:2017, and is positioning itself as a category-defining platform through sub-brands BugSpeaks, RychBiome, and the World of Microbiome conference, with an Faecal Microbiota Transplant service and skin/oral/vaginal microbiome tests in development.

Leucine Rich Bio firmographics

Firmographics
Name
Leucine Rich Bio
Legal name
Leucine Rich Bio Pvt Ltd
Website
https://leucinerichbio.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Leucine Rich Bio is an India-based microbiome genomics company that sells the BugSpeaks gut microbiome test directly to consumers, develops RychBiome supplements, and offers microbiome research services to pharmaceutical and academic clients across India, Malaysia, UAE, the Philippines, and Brazil.
Ownership category
akta.pro rank

Leucine Rich Bio industry classification

Industry
Product category
Microbiome Diagnostics
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Food (Health) Supplement Retailers (456191)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHSADAFAH
Gut Health & Digestive Nutrition (IBS, GERD, Elimination Diets)
SECONDARYHLAAAFAK
Microbiome Clinical Development & Translational Services (trial design, endpoints, sampling)

Keywords

  • Microbiome testing
  • Gut microbiome analysis
  • Personalized nutrition
  • Microbiome diagnostics
  • Probiotic supplements

Where Leucine Rich Bio is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Leucine Rich Bio business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. BugSpeaks Diagnostic Test: Direct-to-consumer microbiome analysis testing service. Customers purchase the BugSpeaks test kit which includes gut microbiome analysis and generates a personalized three-month diet plan based on individual microbial profiles.
  2. RychBiome Supplements: Deep science nutritional supplements developed based on microbiome research, sold as a complementary product line to the diagnostic testing service.
  3. Collaborative Research Services: Research services for CROs, pharmaceutical companies, and academic researchers including cohort studies, deep science ingredient discovery, and drug discovery targeting the microbiome.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goBugSpeaks Microbiome Test

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Leucine Rich Bio product offering

Product offering

Core offering

Leucine Rich Bio provides gut microbiome analysis through its BugSpeaks test, which measures bacterial diversity and generates personalized three-month diet plans based on individual microbial profiles. The company also offers RychBiome deep-science nutritional supplements, microbiome-based skincare products, and collaborative research services for pharmaceutical companies and CROs covering cohort studies, ingredient discovery, and microbiome-targeted drug discovery.

Product overview

Leucine Rich Bio operates as a unified platform centered on microbiome science, consisting of BugSpeaks (core microbiome profiling diagnostic), RychBiome (deep science supplements), World of Microbiome (research conference), and upcoming Faecal Microbiota Transplant services. BugSpeaks serves as the primary diagnostic offering generating personalized nutritional recommendations, while RychBiome extends into therapeutic supplements. Research services for CROs and pharma companies cover gut, oral, skin, vaginal, soil, and built environment microbiomes through collaborative research, cohort studies, deep science ingredients, and drug discovery.

Differentiator

Problem solved

Functional benefit

Brands

  • BugSpeaks: Microbiome profiling platform offering gut microbiome analysis with personalized nutritional recommendations
  • RychBiome
  • World of Microbiome

Products and services

  • BugSpeaks Microbiome profiling test that measures bacterial diversity and generates personalized three-month diet plans based on individual microbial profiles for personalized nutrition and preventive healthcare. Sold directly to consumers.
  • RychBiome Supplements
  • Microbiome-based Skincare Product India's first microbiome-based skincare product, leveraging the company's microbiome science expertise to enter the dermatology and skincare market.
  • Collaborative Research Services Research services for CROs, pharmaceutical companies, and academic researchers including cohort studies, deep science ingredient discovery, and drug discovery targeting the microbiome. Covers gut, oral, skin, vaginal, soil, and built environment microbiomes.

Quantifiable outcome

  • 20% reduction in HbA1c levels in Type 2 diabetes patients following BugSpeaks nutritional recommendations for 3 months
  • +2 more outcomes

Companies that use Leucine Rich Bio

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Leucine Rich Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Leucine Rich Bio partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Trinature WellnesscoreChannel Partner/ Reseller/ DistributorPartnership with Trinature Wellness to launch BugSpeaks microbiome analysis test in Malaysia, expanding the company's presence in Southeast Asia through a local distribution partner.
  • Medsol Diagnostics UAEcoreChannel Partner/ Reseller/ DistributorPartnership with Medsol Diagnostics in UAE to advance microbiome health solutions in the Middle East region, leveraging local healthcare infrastructure and market access.
  • International Distribution Partners (Philippines, Brazil, UAE)minorChannel Partner/ Reseller/ DistributorInternational expansion through partnerships in Philippines, Brazil, and UAE for distribution of BugSpeaks microbiome analysis services in these markets.
  • YUN NVminorStrategic or Co-development PartnerMentioned alongside YUN NV as both being key players in the microbiome space, with Leucine Rich Bio's launch of India's first microbiome-based skincare product highlighted as a significant development.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Leucine Rich Bio competitors and assessment

Company assessment

Direct peers

  • Viome Life Sciences: Viome is a US-based direct-to-consumer microbiome testing company offering gut microbiome analysis with personalized nutrition recommendations. It is the closest global direct competitor to BugSpeaks, operating in the same product category with similar technology (metatranscriptomic sequencing) and targeting health-conscious consumers.
  • DayTwo: DayTwo provides microbiome-based personalized nutrition with clinical validation specifically for Type 2 diabetes and metabolic conditions, mirroring Leucine Rich Bio's clinical trial focus on HbA1c reduction. Both companies target the intersection of microbiome analytics and glycemic management.
  • ZOE: ZOE is a UK/US consumer health company combining microbiome testing with blood sugar and blood fat analysis to deliver personalized nutrition. Like Leucine Rich Bio, ZOE sells DTC microbiome tests with accompanying diet recommendations, often at premium price points for health-conscious consumers.
  • Atlas Biomed: Atlas Biomed is a UK-based microbiome and DNA testing company offering gut microbiome analysis with personalized dietary recommendations. It competes directly in the DTC consumer microbiome testing space and is often compared to Viome and other BugSpeaks-like offerings.
  • Sun Genomics: Sun Genomics offers personalized microbiome testing and custom probiotic formulations direct-to-consumer in the US. The combination of microbiome testing plus a supplement line (Floré) is directly analogous to Leucine Rich Bio's BugSpeaks plus RychBiome model.
  • Biohm Health: Biohm Health provides gut and vaginal microbiome testing with personalized probiotic and prebiotic recommendations. It overlaps with both Leucine Rich Bio's core gut offering and its planned expansion into vaginal microbiome testing.
  • Thryve Inside: Thryve Inside (formerly Thryve) provides gut microbiome testing and analysis services, including white-label microbiome testing for brands. It is comparable to Leucine Rich Bio both in its DTC testing business and its B2B research and co-development services for partner brands and researchers.

Emerging players

  • Daye: Daye is a UK-based femtech company offering vaginal microbiome testing alongside period care products. It is an emerging competitor specifically in the vaginal microbiome category that Leucine Rich Bio plans to enter in 2026.
  • MapMyGut (by Carbiotix): Carbiotix is a Swedish microbiome testing and prebiotic fiber ingredient company offering gut microbiome analysis. It overlaps with Leucine Rich Bio on the diagnostics side and on the gut-health supplement/ingredient adjacency through RychBiome.
  • Siolta Therapeutics: Siolta Therapeutics is a clinical-stage microbiome therapeutics company developing live biotherapeutic products for inflammatory diseases. While focused on therapeutics rather than diagnostics, Siolta is comparable in its deep microbiome R&D approach and represents the kind of therapeutic-direction opportunity Leucine Rich Bio could pursue with its Faecal Microbiota Transplant service.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Leucine Rich Bio social profiles

Digital presence

Leucine Rich Bio compliance and trust

Trust signal

Compliance3 records

Leucine Rich Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Leucine Rich Bio leadership team

Management profile

Number of profiles

Profiles10 records

Leucine Rich Bio funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Leucine Rich Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leucine Rich Bio

What does Leucine Rich Bio do?

Leucine Rich Bio provides gut microbiome analysis through its BugSpeaks test, which measures bacterial diversity and generates personalized three-month diet plans based on individual microbial profiles. The company also offers RychBiome deep-science nutritional supplements, microbiome-based skincare products, and collaborative research services for pharmaceutical companies and CROs covering cohort studies, ingredient discovery, and microbiome-targeted drug discovery.

Is Leucine Rich Bio a public or private company?

Leucine Rich Bio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Leucine Rich Bio founded?

Leucine Rich Bio was founded in 2014. It employs 11 to 50 people.

Where is Leucine Rich Bio based?

Leucine Rich Bio is headquartered in Bangalore, India, in the Asia region.

How does Leucine Rich Bio make money?

Three revenue lines are on record. BugSpeaks Diagnostic Test is the primary driver. The others are rychBiome Supplements and collaborative Research Services.

Who are Leucine Rich Bio's main competitors?

Direct peers on record are Viome Life Sciences, DayTwo, ZOE, Atlas Biomed, Sun Genomics, Biohm Health and Thryve Inside. Emerging players are Daye, MapMyGut (by Carbiotix) and Siolta Therapeutics.

Does Leucine Rich Bio have an API?

No public API is recorded for Leucine Rich Bio.

What industry is Leucine Rich Bio in?

Leucine Rich Bio's product category is Microbiome Diagnostics. Its primary akta.pro industry code is HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal), with a secondary code of HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 541714 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
www.passionateinmarketing.comWorld Of Microbiome 2026 Advances Microbiome ScienceLeucine Rich Bio Pvt Ltd hosted the third edition of World of Microbiome 2026 in Bengaluru, India, bringing together clinicians, researchers, and industry leaders to discuss advancements in microbiome science and precision wellness. The event featured keynotes on integrating AI into microbiome analysis and highlighted the company's decade-long experience and partnerships with over 100 clinical collaborators. Speakers included representatives from Leucine Rich Bio, Unilever India, and IIT Roorkee, focusing on next-generation diagnostics and therapeutics.IndiaWeb2World of Microbiome 2026: Bengaluru Conference by Leucine Rich Bio on Precision Nutrition, Clinical Innovation, and Global Microbiome TrendsLeucine Rich Bio will host the 3rd World of Microbiome 2026 conference on 21 August 2026 at Hotel GreenPark, Bengaluru. The one-day event will feature sessions on microbiota in health, precision nutrition, and clinical trials, with confirmed speakers including company founders and industry experts.www.passionateinmarketing.comLeucine Rich Bio Hosts Microbiome Conference in BengaluruLeucine Rich Bio Pvt Ltd, South Asia's first microbiome company, will host the 3rd edition of its World of Microbiome 2026 conference on 21 August 2026 in Bengaluru, India. The one-day flagship event will bring together clinicians, researchers, nutritionists, biotech leaders, and investors to advance microbiome science, precision nutrition, and preventive healthcare applications. The conference marks the company's continued effort to facilitate knowledge sharing and translate microbiome research into clinical and wellness benefits across South Asia.FortunebusinessinsightsProbiotics Food & Cosmetics Market Size, ShareThe global probiotics food and cosmetics market was valued at USD 71.01 billion in 2025 and is projected to grow to USD 118.08 billion by 2034, exhibiting a CAGR of 5.84%, with Asia Pacific dominating at 48.61% market share. Key industry players including Chr. Hansen Holding A/S, DSM-Firmenich, Yakult Honsha Co., Ltd., Lallemand Inc., and Kerry Group collectively shape global supply through fermentation scale, IP-protected strains, and B2B partnerships with food, nutraceutical, and cosmetic manufacturers. Recent developments include Bausch Health's September 2025 launch of the YUN Probiotherapy ACN skincare line in Poland through a partnership with YUN NV, and Leucine Rich Bio's launch of India's first microbiome-based skincare product, highlighting accelerating convergence of nutrition science and dermatology across functional foods and cosmetics.YourStoryHealth, safety, AI: test your business creativity with Edition 222 of our weekly quiz!The article discusses various innovative startup solutions to social challenges across India, focusing on financial inclusion, traditional art preservation, women's safety, remote healthcare, and diagnostics. Examples include Kaleidofin's AI-based credit tools, initiatives to preserve folk art, BoomBird's safety alarms, O-Health's AI healthcare platform, and Leucine Rich Bio's microbiome analysis. The article highlights efforts to leverage technology for social impact and improved quality of life.YourStory‘Gut’ your health: How Leucine Rich Bio uses microbiome science to personalise preventive healthcareLeucine Rich Bio, a Bengaluru-based startup founded in 2014 by Debojyoti Dhar and Kumar Sankaran, uses gut microbiome analysis to personalise nutrition and preventive healthcare through its flagship BugSpeaks test, priced at Rs 10,000, which measures bacterial diversity and generates a three-month diet plan based on individual microbial profiles. In a registered clinical trial, patients with Type 2 diabetes who followed BugSpeaks nutritional recommendations for three months showed a 20% reduction in HbA1c levels, along with decreases in inflammation markers and blood pressure, with findings published in 2024. The startup, which has analysed over 20,000 samples and built a proprietary database of 2,000 Indian and 10,000 global microbiome profiles, is expanding internationally through partnerships in the Philippines, Brazil, and the UAE, while also developing additional tests for skin, oral, and vaginal microbiomes by April 2026.Polaris Market ResearchMicrobiome Skincare Products Market: Counteracting SensitivityPolaris Market Research reports that the microbiome skincare products market was valued at USD 437.71 million in 2024 and is projected to grow at a CAGR of 12.7% through 2034. Recent industry developments include Leucine Rich Bio Pvt. Ltd. launching a skin microbiome test and Bausch Health introducing a new acne skincare portfolio in Poland following a partnership with YUN NV.Digital Health NewsBengaluru-Based Leucine Rich Bio Secures Pre-Series A Funding for Healthcare InnovationLeucine Rich Bio, a Bengaluru-based microbiome company, secured undisclosed pre-Series A funding to expand its product portfolio and research capabilities, with a focus on microbiome research for healthcare and cancer treatment. The funding aims to develop new healthcare products and enhance branding, reflecting advancements in microbiome applications. In a related healthcare funding event, Bangalore biotech startup Mestastop Solutions raised INR 4.5 Cr to support proof of concept studies on small molecules.TechgraphLeucine Rich Bio Launches Middle East Unit to Tap Microbiome MarketLeucine Rich Bio launched Leucine Rich Bio Middle East FZCO in Dubai to expand into the microbiome wellness market in the GCC and MENA region. The company will introduce BugSpeaks, a microbiome diagnostic test, and Rychbiome, personalized wellness formulations, and will partner with healthcare providers and research institutions to develop region-specific solutions.